Researchers have discovered a potential treatment target to prevent chronic kidney disease patients from developing blood clots without causing bleeding complications.
Students, faculty and staff share their thoughts!
DFCI neuroendocrine tumor specialist appointed Chief of the Section of Hematology/Oncology, Zoltan Kohn Professor of Medicine, Deputy Director of the BU-BMC Cancer Center, effective March 1, 2018.
According to an editorial, the absence of inflammatory and ulcerative lesions in the colon should be the end goal of treating patients with ulcerative colitis.
At BUSM, students from underrepresented groups learn about careers beyond medicine.
Can the disease process be delayed by reducing stress granules and decreasing persistent stress response by genetically decreasing TIA1?
Researchers believe these findings support a paradigm shift in the treatment of both localized and systematic inflammatory conditions.
David Blumenthal, MD, MPP, is president of The Commonwealth Fund, a national philanthropy engaged in independent research on health and social policy issues.
Research was based on the data of 54,337 African American women enrolled in Boston University’s Black Women’s Health Study.
Daniel P. Alford, MD, MPH, has served as Assistant Dean for CME since September 2011.